These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15660391)
1. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis. Zender L; Hütker S; Mundt B; Waltemathe M; Klein C; Trautwein C; Malek NP; Manns MP; Kühnel F; Kubicka S Hepatology; 2005 Feb; 41(2):280-8. PubMed ID: 15660391 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072 [TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Mundt B; Wirth T; Zender L; Waltemathe M; Trautwein C; Manns MP; Kühnel F; Kubicka S Gut; 2005 Nov; 54(11):1590-6. PubMed ID: 16227360 [TBL] [Abstract][Full Text] [Related]
4. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Zhang L; Gu J; Lin T; Huang X; Roth JA; Fang B Gene Ther; 2002 Sep; 9(18):1262-70. PubMed ID: 12215894 [TBL] [Abstract][Full Text] [Related]
6. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766 [TBL] [Abstract][Full Text] [Related]
7. Involvement of TRAIL and its receptors in viral hepatitis. Mundt B; Kühnel F; Zender L; Paul Y; Tillmann H; Trautwein C; Manns MP; Kubicka S FASEB J; 2003 Jan; 17(1):94-6. PubMed ID: 12475902 [TBL] [Abstract][Full Text] [Related]
8. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway. Henson ES; Gibson EM; Villanueva J; Bristow NA; Haney N; Gibson SB J Cell Biochem; 2003 Aug; 89(6):1177-92. PubMed ID: 12898516 [TBL] [Abstract][Full Text] [Related]
10. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP. Kang J; Bu J; Hao Y; Chen F Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917 [TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465 [TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation. Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570 [TBL] [Abstract][Full Text] [Related]